VAR2 Pharmaceuticals
PrivateLast Round
VC Round
Jun 15, 2022
Total Funding Raised
$4.36M
Company Overview
VAR2 Pharmaceuticals operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a VC Round in June 2022.
VAR2 Pharmaceuticals is a biotechnology company that develops first-in-class cancer therapeutics targeting oncofetal Chondroitin Sulfate.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VAR2 Pharmaceuticals Comparables
Compare VAR2 Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlycoNex | 77% | |
| Hummingbird Bioscience | 69% | |
| Siren Biotechnology | 66% |
For institutional investors. Book with your work email.
VAR2 Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 15, 2022 | ||||
| Grant | Jun 15, 2022 | ||||
| Grant | Jun 15, 2022 | ||||
| Grant | Apr 1, 2022 | ||||
| Grant | Jul 6, 2020 | ||||
Seed | Jan 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VAR2 Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Nordisk Foundation | Grant |
| Kirsten og Freddy Johansens Fond | Grant |
| European Union | Grant |
| The University of Copenhagen | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2022
$1.06M grant received from Novo Nordisk Foundation and Kirsten og Freddy Johansens Fond.
- Jun 15, 2022
$11M raised in a VC Round.
For institutional investors. Book with your work email.
VAR2 Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VAR2 Pharmaceuticals's valuation, stock price, and market status.
Is VAR2 Pharmaceuticals a public or private company?
VAR2 Pharmaceuticals is a private company.
What is the current stock price of VAR2 Pharmaceuticals?
VAR2 Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks VAR2 Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VAR2 Pharmaceuticals worth (valuation)?
Valuation information for VAR2 Pharmaceuticals is not publicly available.
Can I buy VAR2 Pharmaceuticals stock?
VAR2 Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VAR2 Pharmaceuticals's last funding round?
VAR2 Pharmaceuticals's most recent funding round was VC Round on June 15, 2022.
Who are the main investors in VAR2 Pharmaceuticals?
Key investors in VAR2 Pharmaceuticals include Novo Nordisk Foundation, Kirsten og Freddy Johansens Fond, European Union, The University of Copenhagen.
Will VAR2 Pharmaceuticals IPO soon?
No public IPO plans have been announced for VAR2 Pharmaceuticals.
How can I track VAR2 Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in VAR2 Pharmaceuticals's shares on secondary markets.